Plain-English translation of NCT07120789 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are building and testing a new survey called the SAVOIR questionnaire to measure how well patients with pulmonary arterial hypertension (PAH)—a serious lung condition affecting blood pressure—understand their disease, symptoms, treatments, and self-care. The goal is to create a tool that doctors can use to identify gaps in patient knowledge and improve education. This validation study involves expert review, patient feedback, and testing with up to 200 patients to ensure the survey is clear, accurate, and helpful.
Right now, there's no standard way to assess how much patients with PAH actually know about their condition. Understanding what patients do and don't know can help doctors provide better education and support, leading to improved medication adherence, better self-management, and potentially better health outcomes.
You likely qualify if…
You likely don't qualify if…
Your involvement depends on which phase of the study you join. If you're a patient with PAH, you may be asked to complete the survey once or twice, talk through your understanding of the questions, or both—sessions typically last less than an hour. Researchers will also review your medical records to gather information about your condition and how well controlled it is. There are no medications to take or invasive procedures involved; this is entirely about answering questions and providing feedback to help improve the survey.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
Brazil